MedTrace Logo

Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic

NCT04460547 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-07-07

No results posted yet for this study

Summary

On 11th of March 2020, WHO characterized COVID-19 infection as a Pandemic. After the COVID-19 infection is declared as a Pandemic there was an outburst regarding COVID-19 Research. The Research interest led to registration of Interventional and Observational studies world wide. There are constant efforts by Health care workers to seek information regarding the Interventional and Observational studies which can help in decision making regarding effective handling of COVID-19 infected patients. It is also important to track on the happenings in various frontiers of COVID-19 Research in view of historical interest and clinical relevance. This Observational Cross sectional study aims to explore the completed Researches in WHO-compliant registries to understand the trends of COVID-19 Research. This study aims to get a birds eye view of ongoing COVID-19 Research scenario worldwide. This study results can directly benefit the worldwide Academicians and Health Care Professionals to understand the ongoing COVID-19 Research trends.

Conditions

Interventions

DRUG

Convalescent Plasma Transfusion

Convalescent Plasma Transfusion to COVID-19 infected patients.

DRUG

Hydroxychloroquine

Hydroxychloroquine administration to COVID-19 infected patients.

DRUG

DAS181

DAS181 administration to COVID-19 infected patients.

DRUG

Ivermectin

Ivermectin administration to COVID-19 infected patients.

DRUG

Interferon Beta-1A

Interferon Beta-1A administration to COVID-19 infected patients.

Sponsors & Collaborators

  • Qassim University

    lead OTHER

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-25
Primary Completion
2020-08-15
Completion
2020-09-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04460547 on ClinicalTrials.gov